Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs in Knee Osteoarthritis
NCT02580695Phase 2Completed
- Start
- Dec 2015
- Primary completion
- Jan 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of umbilical cord-derived mesenchymal stromal cells in osteoarthritis (OA) (3 arms). Primary endpoint: Proportion of patients who experience an adverse event at 12 months. Started Dec 2015; status: completed.
02
Drugs
umbilical cord-derived mesenchymal stromal cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02580695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580695.